nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—SLCO1B1—breast cancer	0.211	0.545	CbGaD
Pantoprazole—ABCG2—breast cancer	0.0919	0.237	CbGaD
Pantoprazole—CYP3A4—breast cancer	0.046	0.119	CbGaD
Pantoprazole—ABCB1—breast cancer	0.0383	0.0988	CbGaD
Pantoprazole—CYP1A2—Anastrozole—breast cancer	0.0178	0.0466	CbGbCtD
Pantoprazole—CYP1A2—Toremifene—breast cancer	0.0162	0.0426	CbGbCtD
Pantoprazole—CYP2C9—Anastrozole—breast cancer	0.016	0.042	CbGbCtD
Pantoprazole—ABCG2—Tamoxifen—breast cancer	0.0144	0.0378	CbGbCtD
Pantoprazole—ABCB1—Toremifene—breast cancer	0.0142	0.0373	CbGbCtD
Pantoprazole—ABCG2—Mitoxantrone—breast cancer	0.014	0.0368	CbGbCtD
Pantoprazole—SLCO1B1—Irinotecan—breast cancer	0.0139	0.0365	CbGbCtD
Pantoprazole—CYP2C19—Lapatinib—breast cancer	0.0128	0.0337	CbGbCtD
Pantoprazole—CYP3A4—Exemestane—breast cancer	0.0123	0.0322	CbGbCtD
Pantoprazole—CYP2C9—Idarubicin—breast cancer	0.0121	0.0318	CbGbCtD
Pantoprazole—ABCG2—Paclitaxel—breast cancer	0.0112	0.0294	CbGbCtD
Pantoprazole—ABCG2—Irinotecan—breast cancer	0.011	0.029	CbGbCtD
Pantoprazole—ABCG2—Fluorouracil—breast cancer	0.0106	0.0278	CbGbCtD
Pantoprazole—ABCG2—Carboplatin—breast cancer	0.0105	0.0277	CbGbCtD
Pantoprazole—CYP3A4—Letrozole—breast cancer	0.0104	0.0274	CbGbCtD
Pantoprazole—ABCB1—Lapatinib—breast cancer	0.0104	0.0272	CbGbCtD
Pantoprazole—CYP3A4—Anastrozole—breast cancer	0.0093	0.0244	CbGbCtD
Pantoprazole—CYP3A4—Toremifene—breast cancer	0.00851	0.0223	CbGbCtD
Pantoprazole—ABCG2—Docetaxel—breast cancer	0.0081	0.0212	CbGbCtD
Pantoprazole—CYP3A4—Fulvestrant—breast cancer	0.00791	0.0208	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—breast cancer	0.00736	0.0193	CbGbCtD
Pantoprazole—CYP3A4—Thiotepa—breast cancer	0.00705	0.0185	CbGbCtD
Pantoprazole—CYP2C9—Capecitabine—breast cancer	0.00664	0.0174	CbGbCtD
Pantoprazole—CYP3A4—Ixabepilone—breast cancer	0.00645	0.0169	CbGbCtD
Pantoprazole—CYP2C19—Tamoxifen—breast cancer	0.00643	0.0169	CbGbCtD
Pantoprazole—CYP3A4—Lapatinib—breast cancer	0.00621	0.0163	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—breast cancer	0.00603	0.0158	CbGbCtD
Pantoprazole—CYP1A2—Tamoxifen—breast cancer	0.00593	0.0156	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—breast cancer	0.00585	0.0153	CbGbCtD
Pantoprazole—ABCB1—Vinorelbine—breast cancer	0.00575	0.0151	CbGbCtD
Pantoprazole—CYP2C9—Tamoxifen—breast cancer	0.00534	0.014	CbGbCtD
Pantoprazole—ABCB1—Tamoxifen—breast cancer	0.00519	0.0136	CbGbCtD
Pantoprazole—ABCB1—Mitoxantrone—breast cancer	0.00506	0.0133	CbGbCtD
Pantoprazole—CYP3A4—Raloxifene—breast cancer	0.0047	0.0123	CbGbCtD
Pantoprazole—ABCB1—Gemcitabine—breast cancer	0.00447	0.0117	CbGbCtD
Pantoprazole—CYP1A2—Fluorouracil—breast cancer	0.00437	0.0115	CbGbCtD
Pantoprazole—CYP2C9—Paclitaxel—breast cancer	0.00416	0.0109	CbGbCtD
Pantoprazole—ABCB1—Paclitaxel—breast cancer	0.00404	0.0106	CbGbCtD
Pantoprazole—ABCB1—Irinotecan—breast cancer	0.00398	0.0105	CbGbCtD
Pantoprazole—CYP2C9—Fluorouracil—breast cancer	0.00394	0.0103	CbGbCtD
Pantoprazole—ABCB1—Vinblastine—breast cancer	0.00354	0.00929	CbGbCtD
Pantoprazole—CYP3A4—Vinorelbine—breast cancer	0.00344	0.00904	CbGbCtD
Pantoprazole—CYP3A4—Tamoxifen—breast cancer	0.00311	0.00816	CbGbCtD
Pantoprazole—CYP3A4—Mitoxantrone—breast cancer	0.00303	0.00795	CbGbCtD
Pantoprazole—ABCB1—Docetaxel—breast cancer	0.00292	0.00766	CbGbCtD
Pantoprazole—CYP3A4—Paclitaxel—breast cancer	0.00242	0.00635	CbGbCtD
Pantoprazole—CYP3A4—Irinotecan—breast cancer	0.00239	0.00626	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—breast cancer	0.00218	0.00571	CbGbCtD
Pantoprazole—CYP3A4—Vinblastine—breast cancer	0.00212	0.00557	CbGbCtD
Pantoprazole—ABCB1—Methotrexate—breast cancer	0.00211	0.00553	CbGbCtD
Pantoprazole—CYP3A4—Docetaxel—breast cancer	0.00175	0.00459	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—breast cancer	0.0013	0.00342	CbGbCtD
Pantoprazole—ATP4B—endocrine gland—breast cancer	0.000877	0.127	CbGeAlD
Pantoprazole—ATP4A—epithelium—breast cancer	0.000607	0.0882	CbGeAlD
Pantoprazole—SLCO1B1—mammary gland—breast cancer	0.000584	0.085	CbGeAlD
Pantoprazole—ATP4A—female reproductive system—breast cancer	0.000451	0.0656	CbGeAlD
Pantoprazole—ATP4A—adrenal gland—breast cancer	0.00044	0.064	CbGeAlD
Pantoprazole—ATP4A—endocrine gland—breast cancer	0.000382	0.0555	CbGeAlD
Pantoprazole—Omeprazole—CYP1B1—breast cancer	0.000352	0.108	CrCbGaD
Pantoprazole—Lansoprazole—CYP1B1—breast cancer	0.000322	0.0988	CrCbGaD
Pantoprazole—Rabeprazole—ABCG2—breast cancer	0.000297	0.0914	CrCbGaD
Pantoprazole—CYP2C9—mammary gland—breast cancer	0.000295	0.0429	CbGeAlD
Pantoprazole—CYP1A2—nipple—breast cancer	0.000257	0.0374	CbGeAlD
Pantoprazole—Omeprazole—ABCG2—breast cancer	0.000242	0.0745	CrCbGaD
Pantoprazole—SLCO1B1—female reproductive system—breast cancer	0.000242	0.0352	CbGeAlD
Pantoprazole—Rabeprazole—CYP1A1—breast cancer	0.000233	0.0716	CrCbGaD
Pantoprazole—Lansoprazole—ABCG2—breast cancer	0.000222	0.0682	CrCbGaD
Pantoprazole—Esomeprazole—CYP3A4—breast cancer	0.000206	0.0632	CrCbGaD
Pantoprazole—SLCO1B1—endocrine gland—breast cancer	0.000205	0.0297	CbGeAlD
Pantoprazole—Omeprazole—CYP1A1—breast cancer	0.00019	0.0584	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A1—breast cancer	0.000174	0.0534	CrCbGaD
Pantoprazole—Rabeprazole—CYP2D6—breast cancer	0.000173	0.0533	CrCbGaD
Pantoprazole—ABCG2—endometrium—breast cancer	0.000161	0.0235	CbGeAlD
Pantoprazole—ABCG2—uterus—breast cancer	0.000149	0.0216	CbGeAlD
Pantoprazole—Rabeprazole—CYP3A4—breast cancer	0.000149	0.0457	CrCbGaD
Pantoprazole—ABCG2—pituitary gland—breast cancer	0.000146	0.0212	CbGeAlD
Pantoprazole—ABCG2—adipose tissue—breast cancer	0.000145	0.0211	CbGeAlD
Pantoprazole—Omeprazole—CYP2D6—breast cancer	0.000141	0.0434	CrCbGaD
Pantoprazole—CYP2C19—endocrine gland—breast cancer	0.000133	0.0194	CbGeAlD
Pantoprazole—ABCG2—adrenal gland—breast cancer	0.00013	0.019	CbGeAlD
Pantoprazole—Lansoprazole—CYP2D6—breast cancer	0.000129	0.0397	CrCbGaD
Pantoprazole—ABCG2—bone marrow—breast cancer	0.000126	0.0183	CbGeAlD
Pantoprazole—CYP2C9—female reproductive system—breast cancer	0.000122	0.0178	CbGeAlD
Pantoprazole—ABCG2—female gonad—breast cancer	0.000122	0.0177	CbGeAlD
Pantoprazole—Omeprazole—CYP3A4—breast cancer	0.000121	0.0373	CrCbGaD
Pantoprazole—Lansoprazole—CYP3A4—breast cancer	0.000111	0.0341	CrCbGaD
Pantoprazole—CYP1A2—endocrine gland—breast cancer	0.000109	0.0158	CbGeAlD
Pantoprazole—ABCB1—embryo—breast cancer	0.000109	0.0158	CbGeAlD
Pantoprazole—CYP2C9—endocrine gland—breast cancer	0.000103	0.015	CbGeAlD
Pantoprazole—Omeprazole—ABCB1—breast cancer	0.000101	0.031	CrCbGaD
Pantoprazole—CYP3A4—female reproductive system—breast cancer	9.31e-05	0.0135	CbGeAlD
Pantoprazole—Lansoprazole—ABCB1—breast cancer	9.23e-05	0.0284	CrCbGaD
Pantoprazole—ABCB1—epithelium—breast cancer	8.87e-05	0.0129	CbGeAlD
Pantoprazole—ABCB1—endometrium—breast cancer	7.96e-05	0.0116	CbGeAlD
Pantoprazole—CYP3A4—endocrine gland—breast cancer	7.88e-05	0.0115	CbGeAlD
Pantoprazole—ABCG2—lymph node—breast cancer	7.82e-05	0.0114	CbGeAlD
Pantoprazole—ABCB1—uterus—breast cancer	7.33e-05	0.0107	CbGeAlD
Pantoprazole—ABCB1—pituitary gland—breast cancer	7.2e-05	0.0105	CbGeAlD
Pantoprazole—ABCB1—adipose tissue—breast cancer	7.17e-05	0.0104	CbGeAlD
Pantoprazole—ABCB1—female reproductive system—breast cancer	6.59e-05	0.00958	CbGeAlD
Pantoprazole—ABCB1—adrenal gland—breast cancer	6.43e-05	0.00935	CbGeAlD
Pantoprazole—ABCB1—bone marrow—breast cancer	6.22e-05	0.00905	CbGeAlD
Pantoprazole—ABCB1—female gonad—breast cancer	6e-05	0.00872	CbGeAlD
Pantoprazole—ABCB1—endocrine gland—breast cancer	5.58e-05	0.00811	CbGeAlD
Pantoprazole—ABCB1—lymph node—breast cancer	3.86e-05	0.00561	CbGeAlD
Pantoprazole—Oedema peripheral—Doxorubicin—breast cancer	1.6e-05	9.77e-05	CcSEcCtD
Pantoprazole—Dysgeusia—Methotrexate—breast cancer	1.6e-05	9.76e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Docetaxel—breast cancer	1.59e-05	9.75e-05	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—breast cancer	1.59e-05	9.75e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Capecitabine—breast cancer	1.59e-05	9.75e-05	CcSEcCtD
Pantoprazole—Fatigue—Docetaxel—breast cancer	1.59e-05	9.73e-05	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—breast cancer	1.59e-05	9.72e-05	CcSEcCtD
Pantoprazole—Nausea—Mitoxantrone—breast cancer	1.59e-05	9.7e-05	CcSEcCtD
Pantoprazole—Nausea—Irinotecan—breast cancer	1.59e-05	9.7e-05	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—breast cancer	1.58e-05	9.68e-05	CcSEcCtD
Pantoprazole—Pain—Docetaxel—breast cancer	1.58e-05	9.66e-05	CcSEcCtD
Pantoprazole—Constipation—Docetaxel—breast cancer	1.58e-05	9.66e-05	CcSEcCtD
Pantoprazole—Back pain—Methotrexate—breast cancer	1.58e-05	9.65e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Capecitabine—breast cancer	1.57e-05	9.62e-05	CcSEcCtD
Pantoprazole—Chills—Epirubicin—breast cancer	1.57e-05	9.62e-05	CcSEcCtD
Pantoprazole—Arrhythmia—Epirubicin—breast cancer	1.57e-05	9.58e-05	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—breast cancer	1.56e-05	9.56e-05	CcSEcCtD
Pantoprazole—Asthenia—Paclitaxel—breast cancer	1.56e-05	9.56e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Capecitabine—breast cancer	1.55e-05	9.5e-05	CcSEcCtD
Pantoprazole—Alopecia—Epirubicin—breast cancer	1.55e-05	9.47e-05	CcSEcCtD
Pantoprazole—Nausea—Gemcitabine—breast cancer	1.55e-05	9.45e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Capecitabine—breast cancer	1.54e-05	9.44e-05	CcSEcCtD
Pantoprazole—Fatigue—Capecitabine—breast cancer	1.54e-05	9.43e-05	CcSEcCtD
Pantoprazole—Pruritus—Paclitaxel—breast cancer	1.54e-05	9.42e-05	CcSEcCtD
Pantoprazole—Vision blurred—Methotrexate—breast cancer	1.54e-05	9.4e-05	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—breast cancer	1.54e-05	9.39e-05	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—breast cancer	1.53e-05	9.38e-05	CcSEcCtD
Pantoprazole—Pain—Capecitabine—breast cancer	1.53e-05	9.35e-05	CcSEcCtD
Pantoprazole—Constipation—Capecitabine—breast cancer	1.53e-05	9.35e-05	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—breast cancer	1.53e-05	9.33e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Docetaxel—breast cancer	1.52e-05	9.3e-05	CcSEcCtD
Pantoprazole—Nausea—Fluorouracil—breast cancer	1.52e-05	9.29e-05	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—breast cancer	1.52e-05	9.27e-05	CcSEcCtD
Pantoprazole—Ill-defined disorder—Methotrexate—breast cancer	1.51e-05	9.25e-05	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—breast cancer	1.51e-05	9.25e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Docetaxel—breast cancer	1.51e-05	9.23e-05	CcSEcCtD
Pantoprazole—Anaemia—Methotrexate—breast cancer	1.51e-05	9.22e-05	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—breast cancer	1.51e-05	9.21e-05	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—breast cancer	1.5e-05	9.2e-05	CcSEcCtD
Pantoprazole—Tension—Epirubicin—breast cancer	1.5e-05	9.16e-05	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—breast cancer	1.5e-05	9.14e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Paclitaxel—breast cancer	1.49e-05	9.11e-05	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—breast cancer	1.48e-05	9.06e-05	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—breast cancer	1.48e-05	9.03e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Capecitabine—breast cancer	1.47e-05	9.01e-05	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—breast cancer	1.47e-05	8.99e-05	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—breast cancer	1.47e-05	8.97e-05	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—breast cancer	1.47e-05	8.96e-05	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—breast cancer	1.47e-05	8.96e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Capecitabine—breast cancer	1.46e-05	8.94e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Docetaxel—breast cancer	1.46e-05	8.93e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Docetaxel—breast cancer	1.46e-05	8.93e-05	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—breast cancer	1.46e-05	8.93e-05	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—breast cancer	1.46e-05	8.9e-05	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—breast cancer	1.45e-05	8.86e-05	CcSEcCtD
Pantoprazole—Dizziness—Paclitaxel—breast cancer	1.44e-05	8.81e-05	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—breast cancer	1.44e-05	8.79e-05	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—breast cancer	1.43e-05	8.76e-05	CcSEcCtD
Pantoprazole—Cough—Methotrexate—breast cancer	1.42e-05	8.7e-05	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—breast cancer	1.42e-05	8.69e-05	CcSEcCtD
Pantoprazole—Urticaria—Capecitabine—breast cancer	1.42e-05	8.68e-05	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—breast cancer	1.42e-05	8.66e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Capecitabine—breast cancer	1.41e-05	8.64e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Capecitabine—breast cancer	1.41e-05	8.64e-05	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—breast cancer	1.41e-05	8.64e-05	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—breast cancer	1.41e-05	8.63e-05	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—breast cancer	1.41e-05	8.62e-05	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—breast cancer	1.4e-05	8.58e-05	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—breast cancer	1.39e-05	8.51e-05	CcSEcCtD
Pantoprazole—Arthralgia—Methotrexate—breast cancer	1.39e-05	8.49e-05	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—breast cancer	1.39e-05	8.49e-05	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—breast cancer	1.39e-05	8.49e-05	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—breast cancer	1.39e-05	8.47e-05	CcSEcCtD
Pantoprazole—Vomiting—Paclitaxel—breast cancer	1.39e-05	8.47e-05	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—breast cancer	1.38e-05	8.46e-05	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.38e-05	8.43e-05	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—breast cancer	1.38e-05	8.42e-05	CcSEcCtD
Pantoprazole—Rash—Paclitaxel—breast cancer	1.37e-05	8.4e-05	CcSEcCtD
Pantoprazole—Dermatitis—Paclitaxel—breast cancer	1.37e-05	8.39e-05	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—breast cancer	1.37e-05	8.39e-05	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—breast cancer	1.37e-05	8.39e-05	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—breast cancer	1.37e-05	8.38e-05	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—breast cancer	1.37e-05	8.37e-05	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—breast cancer	1.37e-05	8.35e-05	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—breast cancer	1.37e-05	8.35e-05	CcSEcCtD
Pantoprazole—Headache—Paclitaxel—breast cancer	1.37e-05	8.35e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Docetaxel—breast cancer	1.36e-05	8.32e-05	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—breast cancer	1.36e-05	8.3e-05	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—breast cancer	1.35e-05	8.25e-05	CcSEcCtD
Pantoprazole—Confusional state—Methotrexate—breast cancer	1.34e-05	8.21e-05	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—breast cancer	1.34e-05	8.2e-05	CcSEcCtD
Pantoprazole—Cough—Epirubicin—breast cancer	1.33e-05	8.14e-05	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—breast cancer	1.33e-05	8.14e-05	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—breast cancer	1.33e-05	8.14e-05	CcSEcCtD
Pantoprazole—Asthenia—Docetaxel—breast cancer	1.33e-05	8.1e-05	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—breast cancer	1.32e-05	8.09e-05	CcSEcCtD
Pantoprazole—Infection—Methotrexate—breast cancer	1.32e-05	8.08e-05	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—breast cancer	1.32e-05	8.06e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Capecitabine—breast cancer	1.32e-05	8.05e-05	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—breast cancer	1.31e-05	8.01e-05	CcSEcCtD
Pantoprazole—Pruritus—Docetaxel—breast cancer	1.31e-05	7.99e-05	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—breast cancer	1.31e-05	7.98e-05	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—breast cancer	1.31e-05	7.98e-05	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—breast cancer	1.3e-05	7.97e-05	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—breast cancer	1.3e-05	7.94e-05	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—breast cancer	1.3e-05	7.94e-05	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—breast cancer	1.3e-05	7.94e-05	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—breast cancer	1.3e-05	7.93e-05	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—breast cancer	1.3e-05	7.92e-05	CcSEcCtD
Pantoprazole—Nausea—Paclitaxel—breast cancer	1.29e-05	7.91e-05	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—breast cancer	1.29e-05	7.9e-05	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.29e-05	7.89e-05	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methotrexate—breast cancer	1.29e-05	7.87e-05	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—breast cancer	1.28e-05	7.85e-05	CcSEcCtD
Pantoprazole—Asthenia—Capecitabine—breast cancer	1.28e-05	7.84e-05	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—breast cancer	1.27e-05	7.79e-05	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—breast cancer	1.27e-05	7.77e-05	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—breast cancer	1.27e-05	7.76e-05	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—breast cancer	1.27e-05	7.76e-05	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—breast cancer	1.27e-05	7.74e-05	CcSEcCtD
Pantoprazole—Pruritus—Capecitabine—breast cancer	1.27e-05	7.73e-05	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—breast cancer	1.26e-05	7.73e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Docetaxel—breast cancer	1.26e-05	7.73e-05	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—breast cancer	1.26e-05	7.68e-05	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—breast cancer	1.25e-05	7.63e-05	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—breast cancer	1.25e-05	7.62e-05	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—breast cancer	1.25e-05	7.62e-05	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—breast cancer	1.24e-05	7.6e-05	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—breast cancer	1.24e-05	7.59e-05	CcSEcCtD
Pantoprazole—Infection—Epirubicin—breast cancer	1.24e-05	7.57e-05	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—breast cancer	1.23e-05	7.53e-05	CcSEcCtD
Pantoprazole—Shock—Epirubicin—breast cancer	1.23e-05	7.49e-05	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—breast cancer	1.22e-05	7.48e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Capecitabine—breast cancer	1.22e-05	7.48e-05	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—breast cancer	1.22e-05	7.47e-05	CcSEcCtD
Pantoprazole—Dizziness—Docetaxel—breast cancer	1.22e-05	7.47e-05	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—breast cancer	1.22e-05	7.46e-05	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—breast cancer	1.22e-05	7.45e-05	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—breast cancer	1.22e-05	7.43e-05	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—breast cancer	1.21e-05	7.41e-05	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—breast cancer	1.21e-05	7.4e-05	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—breast cancer	1.2e-05	7.36e-05	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—breast cancer	1.2e-05	7.36e-05	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—breast cancer	1.2e-05	7.35e-05	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—breast cancer	1.2e-05	7.35e-05	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—breast cancer	1.2e-05	7.35e-05	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—breast cancer	1.2e-05	7.33e-05	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—breast cancer	1.2e-05	7.31e-05	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.19e-05	7.3e-05	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—breast cancer	1.19e-05	7.26e-05	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—breast cancer	1.19e-05	7.26e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—breast cancer	1.19e-05	7.26e-05	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—breast cancer	1.18e-05	7.23e-05	CcSEcCtD
Pantoprazole—Dizziness—Capecitabine—breast cancer	1.18e-05	7.23e-05	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—breast cancer	1.18e-05	7.19e-05	CcSEcCtD
Pantoprazole—Vomiting—Docetaxel—breast cancer	1.17e-05	7.18e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—breast cancer	1.17e-05	7.16e-05	CcSEcCtD
Pantoprazole—Rash—Docetaxel—breast cancer	1.16e-05	7.12e-05	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—breast cancer	1.16e-05	7.12e-05	CcSEcCtD
Pantoprazole—Dermatitis—Docetaxel—breast cancer	1.16e-05	7.11e-05	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—breast cancer	1.16e-05	7.11e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—breast cancer	1.16e-05	7.07e-05	CcSEcCtD
Pantoprazole—Headache—Docetaxel—breast cancer	1.16e-05	7.07e-05	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—breast cancer	1.15e-05	7.05e-05	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—breast cancer	1.15e-05	7.05e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—breast cancer	1.15e-05	7.03e-05	CcSEcCtD
Pantoprazole—Fatigue—Methotrexate—breast cancer	1.15e-05	7.02e-05	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—breast cancer	1.15e-05	7e-05	CcSEcCtD
Pantoprazole—Pain—Methotrexate—breast cancer	1.14e-05	6.96e-05	CcSEcCtD
Pantoprazole—Vomiting—Capecitabine—breast cancer	1.14e-05	6.95e-05	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—breast cancer	1.14e-05	6.94e-05	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—breast cancer	1.13e-05	6.93e-05	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—breast cancer	1.13e-05	6.91e-05	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—breast cancer	1.13e-05	6.9e-05	CcSEcCtD
Pantoprazole—Rash—Capecitabine—breast cancer	1.13e-05	6.89e-05	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—breast cancer	1.13e-05	6.89e-05	CcSEcCtD
Pantoprazole—Dermatitis—Capecitabine—breast cancer	1.13e-05	6.89e-05	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—breast cancer	1.13e-05	6.88e-05	CcSEcCtD
Pantoprazole—Headache—Capecitabine—breast cancer	1.12e-05	6.85e-05	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—breast cancer	1.12e-05	6.84e-05	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—breast cancer	1.12e-05	6.84e-05	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—breast cancer	1.11e-05	6.81e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—breast cancer	1.11e-05	6.79e-05	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—breast cancer	1.11e-05	6.77e-05	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—breast cancer	1.1e-05	6.72e-05	CcSEcCtD
Pantoprazole—Nausea—Docetaxel—breast cancer	1.1e-05	6.71e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Methotrexate—breast cancer	1.1e-05	6.71e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—breast cancer	1.1e-05	6.7e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—breast cancer	1.09e-05	6.65e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—breast cancer	1.08e-05	6.62e-05	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—breast cancer	1.08e-05	6.58e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—breast cancer	1.08e-05	6.58e-05	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—breast cancer	1.07e-05	6.57e-05	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—breast cancer	1.07e-05	6.51e-05	CcSEcCtD
Pantoprazole—Pain—Epirubicin—breast cancer	1.07e-05	6.51e-05	CcSEcCtD
Pantoprazole—Nausea—Capecitabine—breast cancer	1.06e-05	6.49e-05	CcSEcCtD
Pantoprazole—Urticaria—Methotrexate—breast cancer	1.06e-05	6.47e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—breast cancer	1.05e-05	6.43e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Methotrexate—breast cancer	1.05e-05	6.43e-05	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.05e-05	6.42e-05	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—breast cancer	1.04e-05	6.37e-05	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—breast cancer	1.04e-05	6.33e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—breast cancer	1.03e-05	6.28e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—breast cancer	1.03e-05	6.28e-05	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—breast cancer	1.02e-05	6.26e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—breast cancer	1.02e-05	6.23e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—breast cancer	1.01e-05	6.2e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—breast cancer	1e-05	6.13e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—breast cancer	9.95e-06	6.08e-05	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—breast cancer	9.94e-06	6.08e-05	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—breast cancer	9.9e-06	6.05e-05	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—breast cancer	9.86e-06	6.03e-05	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—breast cancer	9.86e-06	6.03e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—breast cancer	9.85e-06	6.02e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—breast cancer	9.85e-06	6.02e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Methotrexate—breast cancer	9.81e-06	6e-05	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—breast cancer	9.55e-06	5.84e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—breast cancer	9.5e-06	5.81e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—breast cancer	9.43e-06	5.76e-05	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—breast cancer	9.42e-06	5.76e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—breast cancer	9.18e-06	5.61e-05	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—breast cancer	9.16e-06	5.6e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—breast cancer	9.11e-06	5.57e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—breast cancer	9.11e-06	5.57e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—breast cancer	9.11e-06	5.57e-05	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—breast cancer	8.94e-06	5.46e-05	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—breast cancer	8.82e-06	5.39e-05	CcSEcCtD
Pantoprazole—Dizziness—Methotrexate—breast cancer	8.8e-06	5.38e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Epirubicin—breast cancer	8.53e-06	5.21e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—breast cancer	8.49e-06	5.19e-05	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—breast cancer	8.47e-06	5.17e-05	CcSEcCtD
Pantoprazole—Rash—Methotrexate—breast cancer	8.4e-06	5.13e-05	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—breast cancer	8.39e-06	5.13e-05	CcSEcCtD
Pantoprazole—Headache—Methotrexate—breast cancer	8.34e-06	5.1e-05	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—breast cancer	8.27e-06	5.06e-05	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—breast cancer	8.24e-06	5.04e-05	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—breast cancer	8.16e-06	4.99e-05	CcSEcCtD
Pantoprazole—Vomiting—Epirubicin—breast cancer	7.92e-06	4.84e-05	CcSEcCtD
Pantoprazole—Nausea—Methotrexate—breast cancer	7.91e-06	4.83e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—breast cancer	7.89e-06	4.82e-05	CcSEcCtD
Pantoprazole—Rash—Epirubicin—breast cancer	7.86e-06	4.8e-05	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—breast cancer	7.85e-06	4.8e-05	CcSEcCtD
Pantoprazole—Headache—Epirubicin—breast cancer	7.81e-06	4.77e-05	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—breast cancer	7.62e-06	4.66e-05	CcSEcCtD
Pantoprazole—Nausea—Epirubicin—breast cancer	7.4e-06	4.52e-05	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—breast cancer	7.33e-06	4.48e-05	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—breast cancer	7.27e-06	4.44e-05	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—breast cancer	7.26e-06	4.44e-05	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—breast cancer	7.22e-06	4.41e-05	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—breast cancer	6.85e-06	4.19e-05	CcSEcCtD
Pantoprazole—CYP2C19—Metabolism—FASN—breast cancer	3.39e-06	5.85e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BCHE—breast cancer	3.38e-06	5.83e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALDOA—breast cancer	3.36e-06	5.8e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP17A1—breast cancer	3.35e-06	5.77e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC5A5—breast cancer	3.34e-06	5.76e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.32e-06	5.72e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS1—breast cancer	3.31e-06	5.72e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ENO1—breast cancer	3.31e-06	5.72e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—breast cancer	3.31e-06	5.71e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—FASN—breast cancer	3.31e-06	5.71e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.3e-06	5.7e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BCHE—breast cancer	3.3e-06	5.69e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOA3—breast cancer	3.26e-06	5.63e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.26e-06	5.62e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC5A5—breast cancer	3.26e-06	5.62e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2D6—breast cancer	3.25e-06	5.61e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A2—breast cancer	3.24e-06	5.59e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA4—breast cancer	3.23e-06	5.58e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CA9—breast cancer	3.23e-06	5.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC2A1—breast cancer	3.22e-06	5.56e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NQO1—breast cancer	3.22e-06	5.56e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.21e-06	5.54e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NCOA2—breast cancer	3.19e-06	5.5e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—MTR—breast cancer	3.17e-06	5.48e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CPT1A—breast cancer	3.17e-06	5.48e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCG2—breast cancer	3.17e-06	5.48e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.15e-06	5.44e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA2—breast cancer	3.15e-06	5.44e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPX2—breast cancer	3.15e-06	5.44e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC2A1—breast cancer	3.14e-06	5.43e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NQO1—breast cancer	3.14e-06	5.43e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CD—breast cancer	3.14e-06	5.42e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP3A4—breast cancer	3.14e-06	5.42e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.13e-06	5.39e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HPGDS—breast cancer	3.11e-06	5.38e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SULT1A1—breast cancer	3.11e-06	5.37e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPX4—breast cancer	3.11e-06	5.37e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALB—breast cancer	3.1e-06	5.35e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HBA1—breast cancer	3.09e-06	5.34e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—FASN—breast cancer	3.09e-06	5.34e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1B1—breast cancer	3.09e-06	5.33e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BCHE—breast cancer	3.08e-06	5.31e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP3A4—breast cancer	3.07e-06	5.29e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC5A5—breast cancer	3.04e-06	5.25e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA1—breast cancer	3.04e-06	5.25e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—IDH1—breast cancer	3.04e-06	5.25e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.03e-06	5.23e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ACHE—breast cancer	3.02e-06	5.21e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTT1—breast cancer	3.02e-06	5.21e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1B1—breast cancer	3.01e-06	5.2e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NAT2—breast cancer	3.01e-06	5.19e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3e-06	5.18e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—NOS3—breast cancer	2.97e-06	5.12e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HSP90AA1—breast cancer	2.96e-06	5.1e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NCOA1—breast cancer	2.95e-06	5.09e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NQO1—breast cancer	2.94e-06	5.07e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC2A1—breast cancer	2.94e-06	5.07e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CD—breast cancer	2.91e-06	5.02e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—STK11—breast cancer	2.9e-06	5.01e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP19A1—breast cancer	2.9e-06	5.01e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.88e-06	4.96e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NCOA1—breast cancer	2.88e-06	4.96e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALB—breast cancer	2.87e-06	4.96e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP3A4—breast cancer	2.86e-06	4.94e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP17A1—breast cancer	2.86e-06	4.93e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.85e-06	4.92e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP19A1—breast cancer	2.83e-06	4.89e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—STK11—breast cancer	2.83e-06	4.89e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ENO1—breast cancer	2.83e-06	4.89e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS1—breast cancer	2.83e-06	4.89e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.82e-06	4.87e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1B1—breast cancer	2.82e-06	4.86e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.78e-06	4.8e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2D6—breast cancer	2.78e-06	4.79e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.76e-06	4.77e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—NOS3—breast cancer	2.75e-06	4.74e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CB—breast cancer	2.74e-06	4.73e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.73e-06	4.7e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOA2—breast cancer	2.72e-06	4.7e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—breast cancer	2.71e-06	4.68e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—COMT—breast cancer	2.7e-06	4.66e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTP1—breast cancer	2.69e-06	4.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NCOA1—breast cancer	2.69e-06	4.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HMOX1—breast cancer	2.65e-06	4.57e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—STK11—breast cancer	2.65e-06	4.57e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP19A1—breast cancer	2.65e-06	4.57e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ITPR1—breast cancer	2.64e-06	4.56e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—FASN—breast cancer	2.64e-06	4.56e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MED12—breast cancer	2.64e-06	4.55e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—DPYD—breast cancer	2.64e-06	4.55e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—COMT—breast cancer	2.63e-06	4.55e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BCHE—breast cancer	2.63e-06	4.54e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTP1—breast cancer	2.62e-06	4.53e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC5A5—breast cancer	2.6e-06	4.49e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDOA—breast cancer	2.59e-06	4.48e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HMOX1—breast cancer	2.59e-06	4.46e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ITPR1—breast cancer	2.58e-06	4.45e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCB1—breast cancer	2.54e-06	4.39e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CB—breast cancer	2.54e-06	4.38e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOA3—breast cancer	2.52e-06	4.35e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—breast cancer	2.51e-06	4.34e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A1—breast cancer	2.51e-06	4.33e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NQO1—breast cancer	2.51e-06	4.33e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A2—breast cancer	2.5e-06	4.32e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TYMS—breast cancer	2.5e-06	4.31e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.49e-06	4.29e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.47e-06	4.26e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—breast cancer	2.47e-06	4.26e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NCOR1—breast cancer	2.47e-06	4.26e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—COMT—breast cancer	2.46e-06	4.25e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.46e-06	4.24e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCG2—breast cancer	2.45e-06	4.23e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CPT1A—breast cancer	2.45e-06	4.23e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTR—breast cancer	2.45e-06	4.23e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTP1—breast cancer	2.45e-06	4.23e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP3A4—breast cancer	2.45e-06	4.23e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TYMS—breast cancer	2.44e-06	4.21e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.44e-06	4.2e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HMOX1—breast cancer	2.42e-06	4.17e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ITPR1—breast cancer	2.41e-06	4.16e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NCOR1—breast cancer	2.41e-06	4.16e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PLA2G4A—breast cancer	2.41e-06	4.16e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—breast cancer	2.41e-06	4.16e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1B1—breast cancer	2.41e-06	4.15e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HPGDS—breast cancer	2.4e-06	4.15e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HBA1—breast cancer	2.39e-06	4.12e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—breast cancer	2.37e-06	4.09e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GPX1—breast cancer	2.36e-06	4.08e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.36e-06	4.07e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A1—breast cancer	2.34e-06	4.04e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ACHE—breast cancer	2.33e-06	4.02e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTT1—breast cancer	2.33e-06	4.02e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ERCC2—breast cancer	2.32e-06	4.01e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCB1—breast cancer	2.32e-06	4e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GPX1—breast cancer	2.31e-06	3.98e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOA1—breast cancer	2.3e-06	3.96e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A1—breast cancer	2.28e-06	3.94e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TYMS—breast cancer	2.28e-06	3.93e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ERCC2—breast cancer	2.27e-06	3.91e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP19A1—breast cancer	2.26e-06	3.91e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—STK11—breast cancer	2.26e-06	3.91e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.25e-06	3.89e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NCOR1—breast cancer	2.25e-06	3.89e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—breast cancer	2.25e-06	3.89e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP17A1—breast cancer	2.21e-06	3.81e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTEN—breast cancer	2.19e-06	3.78e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ENO1—breast cancer	2.18e-06	3.77e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS1—breast cancer	2.18e-06	3.77e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—MTHFR—breast cancer	2.18e-06	3.77e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GPX1—breast cancer	2.16e-06	3.72e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2D6—breast cancer	2.14e-06	3.7e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A1—breast cancer	2.13e-06	3.68e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—MTHFR—breast cancer	2.13e-06	3.68e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.12e-06	3.67e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ERCC2—breast cancer	2.12e-06	3.65e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—COMT—breast cancer	2.1e-06	3.63e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOA2—breast cancer	2.1e-06	3.63e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTP1—breast cancer	2.09e-06	3.61e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HMOX1—breast cancer	2.06e-06	3.56e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ITPR1—breast cancer	2.06e-06	3.56e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—FASN—breast cancer	2.04e-06	3.52e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BCHE—breast cancer	2.03e-06	3.51e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CAV1—breast cancer	2.01e-06	3.47e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC5A5—breast cancer	2.01e-06	3.46e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—MTHFR—breast cancer	1.99e-06	3.43e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCB1—breast cancer	1.98e-06	3.42e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CAV1—breast cancer	1.96e-06	3.39e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TYMS—breast cancer	1.95e-06	3.36e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NQO1—breast cancer	1.94e-06	3.34e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A1—breast cancer	1.94e-06	3.34e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—breast cancer	1.92e-06	3.32e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.92e-06	3.32e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOR1—breast cancer	1.92e-06	3.32e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.92e-06	3.32e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1B1—breast cancer	1.86e-06	3.21e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GPX1—breast cancer	1.84e-06	3.18e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CAV1—breast cancer	1.84e-06	3.17e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—breast cancer	1.83e-06	3.16e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1A1—breast cancer	1.82e-06	3.15e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.82e-06	3.14e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ERCC2—breast cancer	1.81e-06	3.12e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—breast cancer	1.79e-06	3.09e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOA1—breast cancer	1.77e-06	3.06e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.75e-06	3.03e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—STK11—breast cancer	1.75e-06	3.01e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP19A1—breast cancer	1.75e-06	3.01e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—MTHFR—breast cancer	1.7e-06	2.93e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—breast cancer	1.67e-06	2.89e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.67e-06	2.88e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—COMT—breast cancer	1.62e-06	2.8e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTP1—breast cancer	1.62e-06	2.79e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CD—breast cancer	1.61e-06	2.78e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HMOX1—breast cancer	1.59e-06	2.75e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALB—breast cancer	1.59e-06	2.75e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ITPR1—breast cancer	1.59e-06	2.74e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CD—breast cancer	1.57e-06	2.72e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CAV1—breast cancer	1.57e-06	2.71e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALB—breast cancer	1.55e-06	2.68e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—breast cancer	1.55e-06	2.67e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCB1—breast cancer	1.53e-06	2.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NOS3—breast cancer	1.52e-06	2.63e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TYMS—breast cancer	1.5e-06	2.59e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.5e-06	2.59e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NOS3—breast cancer	1.49e-06	2.56e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—breast cancer	1.48e-06	2.56e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOR1—breast cancer	1.48e-06	2.56e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.48e-06	2.56e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CD—breast cancer	1.47e-06	2.54e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALB—breast cancer	1.45e-06	2.5e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—breast cancer	1.43e-06	2.47e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPX1—breast cancer	1.42e-06	2.45e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A1—breast cancer	1.41e-06	2.43e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CB—breast cancer	1.4e-06	2.42e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ERCC2—breast cancer	1.4e-06	2.41e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—breast cancer	1.39e-06	2.4e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NOS3—breast cancer	1.39e-06	2.4e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CB—breast cancer	1.37e-06	2.37e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—breast cancer	1.36e-06	2.35e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—breast cancer	1.36e-06	2.35e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTHFR—breast cancer	1.31e-06	2.26e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CB—breast cancer	1.28e-06	2.21e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—breast cancer	1.27e-06	2.19e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—breast cancer	1.26e-06	2.18e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CD—breast cancer	1.26e-06	2.17e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALB—breast cancer	1.24e-06	2.14e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—breast cancer	1.21e-06	2.1e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CAV1—breast cancer	1.21e-06	2.09e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NOS3—breast cancer	1.19e-06	2.05e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—breast cancer	1.18e-06	2.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—breast cancer	1.11e-06	1.91e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.1e-06	1.9e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CB—breast cancer	1.09e-06	1.89e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—breast cancer	1.08e-06	1.87e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CD—breast cancer	9.69e-07	1.67e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALB—breast cancer	9.57e-07	1.65e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—breast cancer	9.46e-07	1.63e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NOS3—breast cancer	9.15e-07	1.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—breast cancer	8.56e-07	1.48e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CB—breast cancer	8.45e-07	1.46e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—breast cancer	8.37e-07	1.44e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—breast cancer	8.36e-07	1.44e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—breast cancer	7.81e-07	1.35e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—breast cancer	7.3e-07	1.26e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—breast cancer	7e-07	1.21e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—breast cancer	6.83e-07	1.18e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—breast cancer	6.67e-07	1.15e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—breast cancer	6.38e-07	1.1e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—breast cancer	5.45e-07	9.41e-06	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—breast cancer	5.15e-07	8.89e-06	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—breast cancer	4.21e-07	7.26e-06	CbGpPWpGaD
